According to Natera's latest financial reports and stock price the company's current Operating Margin is -54.91%. At the end of 2022 the company had an Operating Margin of -66.67%.
Year | Operating Margin | Change |
---|---|---|
2022 | -66.67% | -11.48% |
2021 | -75.32% | 28.24% |
2020 | -58.73% | 44.56% |
2019 | -40.63% | -18.11% |
2018 | -49.61% | -22.97% |
2017 | -64.41% | 46.21% |
2016 | -44.05% | 19.32% |
2015 | -36.92% | 1041.42% |
2014 | -3.23% | -95.19% |
2013 | -67.26% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | 47.39% | -186.30% | ๐บ๐ธ USA |
Prothena PRTA | -300.60% | 447.44% | ๐ฎ๐ช Ireland |
Paratek Pharmaceuticals
PRTK | -48.35% | -11.95% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.